Curis Lifesciences Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs |

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Curis Lifesciences

DeciZen not available for IPO

10 Year X-Ray of Curis Lifesciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24TTM
ROCE % 17.1%17.5%41.4%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 23.835.435.60
Sales YoY Gr.-49.1%0.5%-
Adj EPS 0.92.29.80
YoY Gr.-148.3%343.4%-
BVPS (₹) -1.60.610.30
Adj Net
Profit
0.51.25.4NAN
Cash Flow from Ops. 53.40.3-
Debt/CF from Ops. 3.64.861-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA0.5%
Adj EPS NANANA343.4%
BVPSNANANA1650.9%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24TTM
Return on
Equity %
-54.1-419.3179.70
Op. Profit
Mgn %
15.29.324NAN
Net Profit
Mgn %
2.13.415.2NAN
Debt to
Equity
-19.550.23-
Working Cap
Days
01662010
Cash Conv.
Cycle
016430

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Curis Lifesciences Ltd.

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹.) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Quarterly Results

 Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %Mar'25 YoY Gr. Rt. %
Sales (₹ Cr.) 0 N/A0 N/A0 N/A0 N/A
Adj EPS (₹) 0 N/A0 N/A0 N/A0 N/A
Op. Profit Mgn % N/A N/AN/A N/AN/A N/AN/A N/A
Net Profit Mgn % N/A N/AN/A N/AN/A N/AN/A N/A

Management X-Ray of Curis Lifesciences:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Curis Lifesciences

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Curis Lifesciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Sun Pharma Inds. 1,683.9 7.5 (0.5%) Large Cap 48,497 47.7 20.9 35.2 5.6
Dr. Reddys Lab 1,107.9 2.6 (0.2%) Large Cap 28,011 64.4 19.6 17.2 2.9
Cipla 1,461.6 7.8 (0.5%) Large Cap 25,774 61.8 15.6 23.5 3.9
Lupin 1,969.1 3.9 (0.2%) Mid Cap 20,011 62.8 9.7 31.3 5.4
Zydus Lifesciences 882.6 -6.5 (-0.7%) Large Cap 19,547 45.1 19.3 19.7 3.9
Glenmark Pharma 1,404.3 -16.7 (-1.2%) Mid Cap 11,813 -6.2 -10.2 - 4.6
Torrent Pharma 3,058.5 -37.8 (-1.2%) Large Cap 10,728 55 14.8 56.3 13.1
Aurobindo Pharma 1,094.7 -12.3 (-1.1%) Mid Cap 10,646 33 17.2 33.5 3.2
Alkem Laboratories 4,704.1 -46.3 (-1%) Mid Cap 9,748 190.9 18.1 24.9 4.6
Mankind Pharma 2,201.1 31.7 (1.5%) Mid Cap 9,265 47.4 19.6 45.7 6.3
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Sales23.7535.4235.58
Operating Expenses 20.1432.1327.09
Manufacturing Costs6.4712.3211.25
Material Costs9.4316.2211.96
Employee Cost 3.222.182.74
Other Costs 1.031.401.13
Operating Profit 3.603.298.49
Operating Profit Margin (%) 15.2%9.3%23.9%
Other Income 0.020.340.31
Interest 1.641.360.90
Depreciation 0.750.730.68
Exceptional Items 000
Profit Before Tax 1.231.547.22
Tax 0.730.311.86
Profit After Tax 0.491.235.36
PAT Margin (%) 2.1%3.5%15.1%
Adjusted EPS (₹)0.92.29.7
Dividend Payout Ratio (%)0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund -0.900.325.68
Share Capital 0.500.500.50
Reserves -1.40-0.185.18
Minority Interest000
Debt1614.8615.83
Long Term Debt12.419.788.70
Short Term Debt3.605.097.13
Trade Payables9.2811.687.48
Others Liabilities 3.022.804.83
Total Liabilities 27.4029.6733.82

Fixed Assets

Gross Block15.3515.9115.98
Accumulated Depreciation3.013.714.39
Net Fixed Assets12.3312.2011.59
CWIP 000
Investments 0.010.010.01
Inventories5.385.118.96
Trade Receivables6.249.4710.04
Cash Equivalents 0.110.150.42
Others Assets3.332.742.80
Total Assets 27.4029.6733.82

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Cash Flow From Operating Activity 4.953.350.28
PBT 1.231.547.22
Adjustment 2.372.021.52
Changes in Working Capital 1.35-0.22-7
Tax Paid 00-1.46
Cash Flow From Investing Activity -0.37-0.55-0.06
Capex -0.38-0.58-0.07
Net Investments 000
Others 0.010.030.01
Cash Flow From Financing Activity -4.58-2.760.05
Net Proceeds from Shares 000
Net Proceeds from Borrowing -3.14-2.63-1.07
Interest Paid -1.62-1.33-0.85
Dividend Paid 000
Others 0.181.201.97
Net Cash Flow -0.010.040.27
PARTICULARSMar'22Mar'23Mar'24
Ratios
ROE (%)N/A0178.51
ROCE (%)N/A17.4841.35
Asset Turnover Ratio0.871.241.12
PAT to CFO Conversion(x)10.12.720.05
Working Capital Days
Receivable Days9681100
Inventory Days835472
Payable Days359236292

Curis Lifesciences Ltd Stock News

No data found.

Curis Lifesciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Curis Lifesciences on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Curis Lifesciences stood at ₹0.00.
The latest P/E ratio of Curis Lifesciences as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Curis Lifesciences as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Curis Lifesciences is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Curis Lifesciences is ₹0.00 ( Cr.) .

About Curis Lifesciences Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...